Work

Aberrant Epidermal Growth Factor Receptor Signaling and Enhanced Sensitivity to EGFR Inhibitors in Lung Cancer

Year: 2005

Type: article

Source: Cancer Research

DOI: 10.1158/0008-5472.226.65.1

Authors: Joseph Amann, Shailaja Kalyankrishna, Pierre P. Massion, Joyce E. Ohm, Luc Girard, Hisayuki Shigematsu, Michael Peyton, Denise Juroske, Yuhui Huang, J. Stuart Salmon, Young H. Kim, Jonathan R. Pollack, Kiyoshi Yanagisawa, Adi Gazdar, John D. Minna, Jonathan M. Kurie, David P. Carbone

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, The University of Texas MD Anderson Cancer Center, The University of Texas Southwestern Medical Center, Stanford Medicine, Stanford University, Aichi Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G2950411093, Novel Reagents and New Biomarkers for Lung Cancer, Targeting Lung Cancer Vulnerabilities, Regulation of Lung Cancer Metastasis by a Procollagen Lysine Hydroxylase, SPORE in Lung Cancer

OpenAlex ID: W1619850371

FWCI: 49.74

Cites: 23

Cited by: 432

Related to: 10